KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
84 hedge funds and large institutions have $110M invested in Kalaris Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.
Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
31
Reduced
23
Closed
12
Calls
$129K
Puts
–
Net Calls
+$129K
Net Calls Change
+$129K
Top Buyers
| 1 |
1
Alkeon Capital Management
New York
|
$10.7M |
| 2 |
GC
2
GMT Capital
Atlanta,
Georgia
|
$7.38M |
| 3 |
3
Renaissance Technologies
New York
|
$1.18M |
| 4 |
4
BlackRock
New York
|
$9.67M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$2.81M |
